Leveraging Physiologically Based Pharmacokinetic Modeling to Optimize Dosing for Lopinavir/ritonavir with Rifampin in Pediatric Patients
Pharmacotherapy(2022)
Key words
drug-drug interactions (DDI),human immunodeficiency virus (HIV),lopinavir (LPV),pediatric,physiologically based pharmacokinetic modeling (PBPK),rifampicin,ritonavir (RTV),tuberculosis (TB)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined